An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Objectives:
1. Objective of main interest
- To assess the drop-out rate caused by adverse event* after 6 weeks treatment
2. Further objectives
- To assess the drop-out rate caused by adverse event* after 1 week treatment
- To assess the pain reduction rate after 6 weeks treatment from baseline
- To assess the Euroquol (EQ-5D) quality of life
- To assess physician's overall satisfaction
- To assess subject's overall satisfaction
- To assess safety